Medtronic PLC Valuation

MDT Stock  USD 86.21  1.47  1.73%   
At this time, the firm appears to be fairly valued. Medtronic PLC secures a last-minute Real Value of $88.82 per share. The latest price of the firm is $86.21. Our model forecasts the value of Medtronic PLC from analyzing the firm fundamentals such as Current Valuation of 130.91 B, profit margin of 0.12 %, and Return On Equity of 0.0795 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Medtronic PLC's valuation include:
Price Book
2.2801
Enterprise Value
130.9 B
Enterprise Value Ebitda
15.2927
Price Sales
3.3941
Forward PE
15.8228
Fairly Valued
Today
86.21
Please note that Medtronic PLC's price fluctuation is very steady at this time. Calculation of the real value of Medtronic PLC is based on 3 months time horizon. Increasing Medtronic PLC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Medtronic PLC's intrinsic value may or may not be the same as its current market price of 86.21, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  86.21 Real  88.82 Target  90.44 Hype  86.21 Naive  85.97
The intrinsic value of Medtronic PLC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medtronic PLC's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
88.82
Real Value
89.87
Upside
Estimating the potential upside or downside of Medtronic PLC helps investors to forecast how Medtronic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medtronic PLC more accurately as focusing exclusively on Medtronic PLC's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
1.351.361.37
Details
Hype
Prediction
LowEstimatedHigh
85.1686.2187.26
Details
Potential
Annual Dividend
LowForecastedHigh
2.232.302.36
Details
33 Analysts
Consensus
LowTarget PriceHigh
82.3090.44100.39
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Medtronic PLC's intrinsic value based on its ongoing forecasts of Medtronic PLC's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Medtronic PLC's closest peers.

Medtronic PLC Cash

1.61 Billion

Medtronic Valuation Trend

Medtronic PLC's real value is important for investors to make better decisions and a more accurate overall view of Medtronic PLC's financial worth over time. Using both Medtronic PLC's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.

Medtronic Revenue by Product

Medtronic PLC Total Value Analysis

Medtronic PLC is now forecasted to have company total value of 130.91 B with market capitalization of 110.57 B, debt of 26.05 B, and cash on hands of 1.54 B. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Medtronic PLC fundamentals before making security assessment based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
130.91 B
110.57 B
26.05 B
1.54 B

Medtronic PLC Investor Information

About 85.0% of the company shares are owned by institutional investors. The book value of Medtronic PLC was now reported as 38.29. The company has Price/Earnings To Growth (PEG) ratio of 1.6. Medtronic PLC last dividend was issued on the 27th of September 2024. The entity had 2:1 split on the 27th of September 1999. Based on the measurements of operating efficiency obtained from Medtronic PLC's historical financial statements, Medtronic PLC may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Profit Margin0.150.1589
Notably Down
Slightly volatile
Total Cash From Operating Activities3.5 B6.8 B
Way Down
Slightly volatile
Operating IncomeB5.1 B
Way Down
Slightly volatile

Medtronic PLC Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Medtronic PLC has an asset utilization ratio of 35.97 percent. This implies that the Company is making $0.36 for each dollar of assets. An increasing asset utilization means that Medtronic PLC is more efficient with each dollar of assets it utilizes for everyday operations.
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Medtronic PLC Ownership Allocation

Medtronic PLC maintains a total of 1.28 Billion outstanding shares. The majority of Medtronic PLC outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Medtronic PLC to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Medtronic PLC. Please pay attention to any change in the institutional holdings of Medtronic PLC as this could imply that something significant has changed or is about to change at the company. Please note that on September 12, 2024, Senator Tommy Tuberville of US Senate acquired $15k to $50k worth of Medtronic PLC's common stock.

Medtronic PLC Profitability Analysis

The company reported the last year's revenue of 32.36 B. Total Income to common stockholders was 3.68 B with profit before taxes, overhead, and interest of 21.71 B.

Medtronic PLC Past Distributions to stockholders

About Medtronic PLC Valuation

The stock valuation mechanism determines Medtronic PLC's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Medtronic PLC based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Medtronic PLC. We calculate exposure to Medtronic PLC's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medtronic PLC's related companies.
Last ReportedProjected for Next Year
Gross Profit19.5 B9.8 B
Pretax Profit Margin 0.15  0.13 
Operating Profit Margin 0.16  0.15 
Net Profit Margin 0.11  0.12 
Gross Profit Margin 0.60  0.65 

Medtronic PLC Quarterly Retained Earnings

30.92 Billion

Medtronic PLC's stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether Medtronic PLC's value is low or high relative to the company's performance and growth projections. Determining the market value of Medtronic PLC can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of Medtronic PLC represents a small ownership stake in the entity. As a stockholder of Medtronic, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

Medtronic PLC Dividends Analysis For Valuation

At this time, Medtronic PLC's Dividends Paid is comparatively stable compared to the past year. Dividend Paid And Capex Coverage Ratio is likely to gain to 1.39 in 2024, whereas Dividend Yield is likely to drop 0.02 in 2024. . At this time, Medtronic PLC's Retained Earnings are comparatively stable compared to the past year. Price Earnings Ratio is likely to gain to 48.83 in 2024, whereas Retained Earnings Total Equity is likely to drop slightly above 26.6 B in 2024.
Last ReportedProjected for Next Year
Dividends Paid3.7 B3.8 B
Dividend Yield 0.03  0.02 
Dividend Payout Ratio 1.00  0.87 
Dividend Paid And Capex Coverage Ratio 1.29  1.39 
There are various types of dividends Medtronic PLC can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Medtronic shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Medtronic PLC directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Medtronic pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Medtronic PLC by the value of the dividends paid out.

Medtronic PLC Growth Indicators

Investing in growth stocks can be very risky. If the company such as Medtronic PLC does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding1.3 B
Quarterly Earnings Growth Y O Y0.356
Forward Price Earnings15.8228

Medtronic PLC Current Valuation Indicators

Medtronic PLC's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Medtronic PLC's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Medtronic PLC, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Medtronic PLC's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Medtronic PLC's worth.

Additional Tools for Medtronic Stock Analysis

When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.